跳至主要内容
临床试验/NCT03787563
NCT03787563Unknown不适用

Herbal Tea for a Control of Blood Sugar in Subjects With Early Type 2 Diabetes: A Pilot Randomized Placebo Controlled Crossover Study

Composite Interceptive Med Science1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
10
试验地点
1
主要终点
Oral Glucose Tolerance Test (OGTT)

研究概览

简要总结

Diabetes mellitus is a chronic disease caused by inherited and/or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. It has become a major healthcare problem in India. High-quality, low-cost solutions adapted to the local context are critical to addressing the current crisis in the management of diabetes. Herbal tea consists of tulsi, guava and stevia, which has glucose lowering properties.The aim of this trial is to study the effect of a herbal tea in the glycemic response in the early type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Double blinded study

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged over 18 years and having a diagnosis of diabetes and meeting one of the following criteria
  • Fasting Plasma Glucose ≥126 mg/dL, fasting defined as no caloric intake for at least 8 hours, AND
  • 2-h Post load Glucose ≥140 mg/dL during an OGTT. AND
  • Glycosylated haemoglobin (A1C) ≥ 6.5 %.

排除标准

  • Any one of the following
  • Patients on Insulin therapy.
  • Patients on oral hypoglycemic agents other than metformin
  • Any history suggestive of micro vascular or macro vascular disease - coronary artery disease, stroke, peripheral artery disease or diabetes related retinal changes.
  • Women in child bearing age unable to practice any form of contraception
  • Patients with diagnosis of Anaemia (Hemoglobin <11 g/dl in Female and <13 g/dl in Male)
  • Impaired renal function; estimated glomerular function <60mls/min/1.73m
  • Known history of any chronic illness taking regular pharmacological agents.
  • Blood pressure fluctuations exceeding 20 mmHg on 2 subsequent clinic visits or known history of hypotension or bradycardia in last 6 months or taking 3 or more antihypertensive medications regularly in the last 6 weeks
  • Known history of autonomic dysfunction like diabetic autonomic neural imbalance or neuropathy
  • Participating in another clinical trial with an active intervention or drug or device with last dose taken within 60 days.

研究组 & 干预措施

Active Herbal tea

Active Comparator

One tea bag infusion three times a day each before breakfast, lunch and dinner.

干预措施: Herbal Tea (Drug)

Placebo Tea

Placebo Comparator

Similar looking tea bag infusion three times a day each before breakfast, lunch and dinner.

干预措施: Placebo Tea (Drug)

结局指标

主要结局

Oral Glucose Tolerance Test (OGTT)

时间窗: 2 days and 5 days

Change from baseline in OGTT

Fasting Plasma Glucose (FPG)

时间窗: 2 days and 5 days

Change from baseline in Fasting plasma glucose

Number of Subject with adverse events

时间窗: 2 days and 5 days

Adverse events is defined as any untoward medical occurrence that may not necessarily have a causal relationship with the treatment, but resulted in a dose reduction or discontinuation of treatment.

次要结局

  • Flash Glucose Measurements(2 days and 5 days)

研究者

发起方
Composite Interceptive Med Science
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验